Instrument Inactif

Communiqués Cesca Therapeutics Inc Nasdaq

Actions

US1571311034

Equipements électroniques de bureau

Communiqués

11/07/24	ThermoGenesis : Accelaration/Increase of Financial Obligation Form 8 K	PU
20/03/24	ThermoGenesis : Material Event - Form 8-K	PU
13/11/23	ThermoGenesis Holdings Announces Third Quarter 2023 Financial Results and Provides Corporate Update	PR
08/11/23	ThermoGenesis Holdings to Announce Financial Results for the Third Quarter Ended September 30, 2023, and Provide a Corporate Strategic Update	PR
26/10/23	ThermoGenesis to Open a New 35,500 Square Foot ReadyStart-IncuStart cGMP Facility in Greater Sacramento	PR
06/09/23	ThermoGenesis Holdings to Present at the H.C. Wainwright 25th Annual Global Investment Conference	PR
10/08/23	ThermoGenesis Holdings Announces Second Quarter 2023 Financial Results and Provides Corporate Update	PR
08/08/23	ThermoGenesis Holdings to Announce Financial Results for the Second Quarter ended June 30, 2023 and Provide a Corporate Strategic Update	PR
17/07/23	ThermoGenesis Expands Board of Directors with the Appointments of Dr. Biao Xi and Dr. James Xu	PR
17/07/23	ThermoGenesis : Expands Board of Directors with the Appointments of Dr. Biao Xi and Dr. James Xu	PU
15/05/23	ThermoGenesis Holdings Announces First Quarter 2023 Financial Results and Provides Corporate Update	PR
10/05/23	ThermoGenesis Holdings to Announce Financial Results for the First Quarter Ended March 31, 2023 and Provide a Corporate Strategic Update	PR
30/03/23	THERMOGENESIS HOLDINGS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	AQ
30/03/23	THERMOGENESIS HOLDINGS, INC. : Results of Operations and Financial Condition (form 8-K)	AQ
30/03/23	ThermoGenesis Holdings Announces Year End 2022 Financial Results and Provides Corporate Update	PR
28/03/23	ThermoGenesis Holdings to Announce Financial Results for the Year Ended December 31, 2022 and Provide a Corporate Strategic Update	PR
21/03/23	THERMOGENESIS HOLDINGS, INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Other Events, Financial Statements and Exhibits (form 8-K)	AQ
20/03/23	THERMOGENESIS CLOSES $3 MILLION PRIVATE PLACEMENT PRICED AT-THE-MARKET UNDER NASDAQ RULES	PR
16/03/23	THERMOGENESIS ANNOUNCES $3 MILLION PRIVATE PLACEMENT PRICED AT-THE-MARKET UNDER NASDAQ RULES	PR
15/03/23	ThermoGenesis Announces Roll Out of ReadyStart cGMP Suites for Early-Stage Cell and Gene Therapy Companies	PR
10/03/23	ThermoGenesis : Material Agreement - Form 8-K	PU
10/03/23	THERMOGENESIS HOLDINGS, INC. : Entry into a Material Definitive Agreement, Material Modification to Rights of Security Holders, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year (form 8-K)	AQ
27/02/23	ThermoGenesis : Submission of Matters to a Vote of Security Holders - Form 8-K	PU
27/02/23	THERMOGENESIS HOLDINGS, INC. : Submission of Matters to a Vote of Security Holders, Other Events (form 8-K)	AQ
06/02/23	THERMOGENESIS HOLDINGS, INC. : Entry into a Material Definitive Agreement (form 8-K)	AQ